THBS1

From Wikipedia, the free encyclopedia


Thrombospondin 1
PDB rendering based on 1lsl.
Available structures: 1lsl, 1ux6, 1z78, 1za4, 2erf, 2es3
Identifiers
Symbol(s) THBS1; THBS; TSP; TSP1
External IDs OMIM: 188060 MGI98737 HomoloGene31142
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 7057 21825
Ensembl ENSG00000137801 n/a
Uniprot P07996 n/a
Refseq NM_003246 (mRNA)
NP_003237 (protein)
NM_011580 (mRNA)
NP_035710 (protein)
Location Chr 15: 37.66 - 37.68 Mb n/a
Pubmed search [1] [2]

Thrombospondin 1, also known as THBS1, is a human gene.

The protein encoded by this gene is a subunit of a disulfide-linked homotrimeric protein. This protein is an adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions. This protein can bind to fibrinogen, fibronectin, laminin, type V collagen and integrins alpha-V/beta-1. This protein has been shown to play roles in platelet aggregation, angiogenesis, and tumorigenesis.[1]

[edit] See also

Thrombospondin

[edit] References

[edit] Further reading

  • Roberts DD (1996). "Regulation of tumor growth and metastasis by thrombospondin-1.". FASEB J. 10 (10): 1183–91. PMID 8751720. 
  • Adams JC (1997). "Thrombospondin-1.". Int. J. Biochem. Cell Biol. 29 (6): 861–5. PMID 9304800. 
  • Sargiannidou I, Qiu C, Tuszynski GP (2004). "Mechanisms of thrombospondin-1-mediated metastasis and angiogenesis.". Semin. Thromb. Hemost. 30 (1): 127–36. doi:10.1055/s-2004-822977. PMID 15034804. 
  • Esemuede N, Lee T, Pierre-Paul D, et al. (2004). "The role of thrombospondin-1 in human disease.". J. Surg. Res. 122 (1): 135–42. doi:10.1016/j.jss.2004.05.015. PMID 15522326. 
  • Li Z, Wang C, Prendergast GC, Pestell RG (2007). "Cyclin D1 functions in cell migration.". Cell Cycle 5 (21): 2440–2. PMID 17106256. 
  • Roberts DD, Isenberg JS, Ridnour LA, Wink DA (2007). "Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis.". Clin. Cancer Res. 13 (3): 795–8. doi:10.1158/1078-0432.CCR-06-1758. PMID 17289869. 
  • Kaczorowski DJ, Billiar TR (2007). "Targeting CD47: NO limit on therapeutic potential.". Circ. Res. 100 (5): 602–3. doi:10.1161/01.RES.0000261609.44977.25. PMID 17363705.